Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males

Circulation

Volumn 97, Issue 18, 1998, Pages

  Fornage, Myriam ^c   Amos, Christopher I ^c   Kardia, Sharon ^c   Sing, Charles F ^c   Turner, Stephen T ^a   Boerwinkle, Eric ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c NONE

Author keywords

Angiotensin converting enzyme; Blood pressure; Linkage analysis; Males; Whites

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE LOCUS; GENETIC LINKAGE; GENETIC VARIABILITY; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; NORMAL HUMAN; PEDIGREE ANALYSIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE;

EID: 0344193095     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.97.18.1773     Document Type: Article

References (56)

1. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic. and cardiovascular risks: US population data. Arch Intern Med. 1993, 153:598-615.
2. Whelton PK. Epidemiology of hypertension. Lancet. 1994;344:101-106.
3. Laragh JH. The renin system and the renal regulation of blood pressure. In: Seldin DW, Giebisch G, eds. The Kidney: Physiology and Pathophysiology. 2nd ed. New York, NY: Raven Press Ltd; 1992:1411-1453.
4. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel J-M, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
5. Bonnardeaux A, Davies E, Jeunemaitre X, Féry I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin II type l receptor gene polymorphisms in human essential hypertension. Hypertension. 1994;24:63-69.
6. Turner ST, Weidman WH, Michels VV, Reed TJ, Ormson CL, Fuller T, Sing CF. Distribution of sodium-lithium countertransport and blood pressure in Caucasians five to eighty-nine years of age. Hypertension. 1989;13:378-391.
7. Turner ST, Michels VV. Sodium-lithium countertransport and hypertension in Rochester, Minnesota. Hypertension. 1991;18:183-190.
8. Jeunemaitre X, Lifton R, Hunt SC, Williams RR, Lalouel J-M. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet. 1992;1:72-75.
9. Kotelevtsev YV, Clauser E, Corvol P, Soubrier F. Dinucleotide repeat polymorphism in the human angiotensinogen gene. Nucleic Acids Res. 1991;19:6978.
10. Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics. 1992;12:241-253.
11. Davies E, Bonnardeaux A, Lathrop GM, Corvol P, Clauser E, Soubrier F. Angiotensin II (type 1) receptor locus: CA repeat polymorphism and genetic mapping. Hum Mol Genet. 1994;3:838.
12. Curtis D, Sham PC. Using risk calculation to implement an extended relative pair analysis. Ann Hum Genet. 1994;58:151-162.
13. Haseman JK, Elston RC. The investigation of linkage between a quantitative trait and a marker locus. Behav Genet. 1972;2:3-19.
14. Amos CI, Zhu D, Boerwinkle E. Assessing genetic linkage and association with robust components of variance approaches. Ann Hum Genet. 1996;60:143-160.
15. Blangero J. Genetic analysis of a common oligogenic trait with quantitative correlates: summary of GAW9 results. Genet Epidemiol. 1995;12:689-706.
16. Wright FA. The phenotypic difference discards sib-pair QTL linkage information. Am J Hum Genet. 1997;60:740-742.
17. Amos CI. Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet. 1994;54:535-543.
18. Sorant AJM, Elston RC. A Subroutine Package for Function Maximization (A User's Guide to MAXFUN Version 60) SAGE. New Orleans, La: Department of Biometry and Genetics, Louisiana State University; 1994.
19. Hopper JL, Mathews JD. Extension to multivariate normal models for pedigrees analysis. Ann Hum Genet. 1982;46:373-383.
20. Reilly SL, Ferrell RE, Kottke BA, Kamboh MJ, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN, I: pleiotropic effects on means and variances. Am J Hum Genet. 1991;49:1155-1166.
21. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJL. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994;33:1629-1633.
22. Jeunemaitre X, Rigat B, Charru A, Houot A-M, Soubrier F, Corvol P. Sib pair linkage analysis of renin haplotypes in human essential hypertension. Hum Genet. 1992;88:301-306.
23. Morris BJ, Griffiths LR. Frequency in hypertensives of alleles for a RFLP associated with the renin gene. Biochem Biophys Res Commun. 1988;150:219-224.
24. Soubrier F, Jeunemaitre X, Rigat B, Houot A-M, Cambien F, Corvol P. Similar frequencies of renin gene restriction fragment length polymorphisms in hypertensive and normotensive subjects. Hypertension. 1990;16:712-717.
25. Zee RYL, Ying L-H, Morris BJ, Griffiths LR. Association and linkage analyses of restriction fragment length polymorphisms for the human renin and antuhrombin III genes in essential hypertension. J Hypertens. 1991;9:825-830.
26. Greenberg DA. Linkage analysis of "necessary" disease loci versus "susceptibility" loci. Am J Hum Genet. 1993;52:135-143.
27. Risch N, Merikangas K. The future of genetic studies of complex diseases. Science. 1996;273:1516-1517.
28. Hansson L, Dahlöf B, Himmelmann A, Svensson A. Angiotensinconverting enzyme inhibitors in the treatment of essential hypertension. In: Robertson JIS, Nicholls MG, eds. The Renin-Angiotensin System. London, England: Gower Medical Publishing: 1993:91.1-93.24.
29. Hilbert P, Lindpaintner K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, Cartwright P, De Gouyon B, Julier C, Takahasi S, Vincent M, Ganten D, Georges M, Lathrop GM. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature. 1991;353:521-529.
30. Jacob HJ, Lindpaintner K, Lincoln SE, Kusumi K, Bunker RK, Mao Y-P, Ganten D, Dzau VJ, Lander ES. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell. 1991;67:213-224.
31. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
32. Harrap SB, Davidson R, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJW, Watt GCM. The angiotensin I converting enzyme and predisposition to high blood pressure. Hypertension. 1993;21:455-460.
33. Schmidt S, van Hooft IMS, Grobbee DE, Ganten D, Ritz E. Polymorphism of the angiotensin I convening enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring study. J Hypertens. 1993;11:345-348.
34. Duru K, Farrow S, Wang J-M, Lockette W, Kurtz T. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens. 1994;7:759-762.
35. Morris BJ, Zee RYL, Schrader AP. Different frequencies of angiotensinconverting enzyme genotypes in older hypertensive individuals. J Clin Invest. 1994;94:1085-1089.
36. Johnson AG, Simons LA, Friedlander Y, Simons J, Davis DR, MaCallum J. I/D polymorphism of the angiotensin-converting enzyme gene does not predict isolated systolic or systolic-diastolic hypertension in the elderly. J Hum Hypertens. 1996;10:167-169.
37. Vassilikioti S, Doumas M, Douma S, Petidis K, Karagiannis A, Balaska K, Vyzantiadis A, Zamboulis C. Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. Am J Hypertens. 1996;9:700-702.
38. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation. 1998;97:1766-1772.
39. Schunkert H, Hense H-W, Muscholl M, Luchner A, Riegger GAJ. Association of angiotensin converting enzyme activity and arterial blood pressure in a population-based sample. J Hypertens. 1996;14:571-575.
40. Alhenc-Gelas F, Richard J, Courbon D, Warnet JM, Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med. 1991;117:33-39.
41. Watt GCM, Harrap SB, Foy CJW, Holton DW, Edwards HV, Davidson HR, Connor JM, Lever AF, Fraser R. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corner approach to the identification of genetic determinants of blood pressure. J Hypertens. 1992;10:473-482.
42. Krege JH, John SWM, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, Smithies O. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature. 1995;375:146-148.
43. Kreutz R, Stock P, Struk B, Lindpaintner K. The Y chromosome: epistatic and ecogenetic interactions in genetic hypertension. Hypertension. 1996;28:895-897.
44. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation analysis, that a variant of the angiotensin-I converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51:197-205.
45. Axelrod J. Purification and properties of the phenylethanolamine-Nmethyl transferase. J Biol Chem. 1962;237:1657-1660.
46. Reis DJ, Morrison S, Ruggiero DA. The C1 area of the brainstem in tonic and reflex control of blood pressure. Hypertension. 1988:11(suppl I):I-8-I-13.
47. Saavedra JM, Grobecker H, Axelrod J. Adrenaline-forming enzyme in brainstem: elevation in genetic and experimental hypertension. Science. 1976;191:483-484.
48. Chalmer JP, Minson J, Denoroy L, Stead B, Howe PRC. Brainstem PNMT neurons and experimental hypertension in the rat. Clin Exp Hypertens [A]. 1984;6:243-258.
49. Thorner MO, Vance ML. Growth hormone. J Clin Invest. 1988;82:745-747.
50. Karlberg BE, Ottosson A-M. Acromegaly and hypertension: role of the renin-angiotensin-aldosterone system. Acta Endocrinol. 1982;100:581-587.
51. Ho KY, Weissenberger J. The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism. 1990;39:133-137.
52. Herlitz H, Jonsson O, Bentsson B-A. Effect of recombinant human growth hormone on cellular sodium metabolism. Clin Sci. 1994;86:233-237.
53. Brautusch-Marrain PR, Smith D, DeFronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab. 1982;55:973-982.
54. O'Neal DN, Kalfas A, Dunning PL, Christopher MJ, Sawyer SD, Ward GM, Alford FP. The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated disposal and insuline secretion in GH-deficient adults: a minimal model analysis. J Clin Endocrinol Metab. 1994;79:975-983.
55. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
56. Reaven GM. Insulin resistance, hyperinsulinemia and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med. 1991;90:7S-12S.